At a glance
- Originator Targacept
- Developer sanofi-aventis; Targacept
- Class Neuroprotectants; Pyridines
- Mechanism of Action Nicotinic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease